Benign prostatic hyperplasia--review of treatment options.
Oehlke
Kelley J
KJ
South Dakota State University College of Pharmacy and Clinical Pharmacy, Sioux Falls VA Medical Center, USA.
Branaugh
Molly L
ML
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011470:Prostatic Hyperplasia / Q000150:complications / Q000188:drug therapy*; D016055:Urinary Retention / Q000188:drug therapy* / Q000209:etiology
D058891:5-alpha Reductase Inhibitors; D000317:Adrenergic alpha-Antagonists; D004791:Enzyme Inhibitors